Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA ‘State Of Quality’ Report Targets Unreviewed, Uninspected Risks
May 16 2019
•
By
Bowman Cox
Uninspected facilities making unreviewed drugs have poorest quality, FDA finds.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance